4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-20-016461
EVP, North America Commercial sold 463 shares at $11.37 ($5,262)
- EVP, North America Commercial acquired 1,166 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
O'Grady Brendan P. · EVP, North America Commercial
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-03-03 | Exercise or conversion : show line 1 in the form | +1,166 | 14,622.49 | D | ||
| 2020-03-03 | Sale : show line 2 in the form | −463 | $11.37 | $5,262 | 14,159.49 | D |
| Open-market sales · 463 sh · avg $11.37 · $5,262 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-03-03 | Exercise or conversion : show line 3 in the form Restricted Share Units | −1,166 | 1,166 | D |
Loading xslF345X03/doc4.xml…